Targeted transduction of CD34+ cells by transdominant negative rev-expressing retrovirus yields partial anti-HIV protection of progeny macrophages

Human Gene Therapy

Volumn 9, Issue 8, 1998, Pages 1197-1207

  Davis, Brian R ^a,b,d   Saitta, Francis P ^a   Bauer, Gerhard ^a   Bunnell, Bruce A ^c   Morgan, Richard A ^c   Schwartz, David H ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN;

ARTICLE; CELL CULTURE; COLONY FORMING UNIT GM; CONGENITAL INFECTION; CONTROLLED STUDY; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; MACROPHAGE; MONOCYTE; NONHUMAN; RETROVIRUS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES; UNIDENTIFIED RETROVIRUS;

EID: 0032550755     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1998.9.8-1197     Document Type: Article

References (17)

1. AKKINA, R.K., ROSENBLATT, J.D., CAMPBELL, A.G., CHEN, I.S., and ZACK, J.A. (1994). Modeling human lymphoid precursor cell gene therapy in the SCID-hu mouse. Blood 84, 1393-1398.
2. BAHNER, I., ZHOU, C., YU, X.J., HAO, Q.L., GUATELLI, J.C., and KOHN, D.B. (1993). Comparison of trans-dominant inhibitory mutant human immunodeficiency virus type 1 genes expressed by retro-viral vectors in human T lymphocytes. J. Virol. 67, 3199-3207.
3. BAHNER, I., KEARNS, K., HAO, Q.L., SMOGORZEWSKA, E.M., and KOHN, D.B. (1996). Transduction of human CD34(+) hematopoietic progenitor cells by a retroviral vector expressing an RRE dcoy inhibits human immunodeficiency virus type 1 replication in myelomonocytic cells produced in long-term culture. J. Virol. 70, 4352-4360.
4. BEVEC, D., DOBROVNIK, M., HAUBER, J., and BOHNLEIN, E. (1992). Inhibition of human immunodeficiency virus type 1 replication in human T cells by retroviral-mediated gene transfer of a dominant-negative Rev trans-activator. Proc. Natl. Acad. Sci. U.S.A. 89, 9870-9874.
5. BORDIGNON, C., NOTARANGELO, L.D., NOBILI, N., FERRARI, G., CASORATI, G., PANINA, P., MAZZOLARI, E., MAGGIONI, D., ROSSI, C., SERVIDA, P., UGAZIO, A.G., and MAVILIO, F. (1995). Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients. Science 270, 470-475.
6. BRENNER, M.K., RILL, D.R., HOLLADAY, M.S., HESLOP, H.E., MOEN, R.C., BUSCHLE, M., KRANCE, R.A., SANTANA, V.M., ANDERSON, W.F., and IHLE, J.N. (1993). Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet 342, 1134.
7. CAROW, C.E., HANGOC, G., and BROXMEYER, H.E. (1993). Human multipotential progenitor cells (CFU-GEMM) have extensive replating capacity for secondary CFU-GEMM: An effect enhanced by cord blood plasma. Blood 81, 942-949.
8. CASSEL, A., COTTLER-FOX, M., DOREN, s., and DUNBAR, C. (1995). Retroviral-mediated gene transfer into CD34-enriched human peripheral blood stem cells. Exp. Hematol. 21, 585-591.
9. CIVIN, C.I. (1990). Human monomyeloid cell membrane antigens. Exp. Hematol. 18, 461-467. [Review]
10. COCCHI, F., DEVICO, A.L., GARZINE-DEMO, A., ARYA, S.K., GALLO, R.C., and LUSSO, P. (1995). Identification of RANTES, MIP-1α, and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells. Science 270, 1811-1815.
11. COLLIER, A.C., COOMBS, R.W., SCHOENFELD, D.A., BASSETT, R.L., TIMPONE, J., BARUCH, A., JONES, M., FACEY, K., WHITACRE, C., MCAULIFFE, V.J., FRIEDMAN, H.M., MERIGAN, T.C., REICHMAN, R.C., HOOPER, C., and COREY, L. (1996). Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine, AIDS Clinical Trials Group. N. Engl. J. Med. 334, 1011-1017.
12. DAVIS, B.R., SCHWARTZ, D.H., MARX, J.C., JOHNSON, C.E., BERRY, J.M., LYDING, J., MERIGAN, T.C., and ZANDER, A. (1991). Absent or rare human immunodeficiency virus infection of bone marrow stem/progenitor cells in vivo. J. Virol. 65, 1985-1990.
13. DEROSSI, A., MASIERO, S., GIAQUINTO, C., RUGA, E., COMAR, M., GIACCA, M., and CHIECOBIANCHI, L. (1996). Dynamics of viral replication in infants with vertically acquired human immunodeficiency virus type 1 infection. J. Clin. Invest. 97, 323-330.
14. DONAHUE, R.E., BUNNELL, B.A., ZINK, M.C., METZGER, M.E., WERSTO, R., KIRY, M., UNANGST, T., CLEMENTS, J.E., and MORGAN, R.A. (1998). Reduction in SIV replication in rhesus macaques infused with autologous lymphocytes engineered with antiviral genes. Nature Med. 4, 1-6.
15. HSUEH, F.W., WALKER, C.M., BLACKBOURN, D.J., and LEVY, J.A. (1994). Suppression of HIV replication by CD8+ cell clones derived from HIV-infected and uninfected individuals. Cell. Immunol. 159, 271-279.
16. XU, L.C., KARLSSON, S., BYRNE, E.R., KLUEPFEL-STAHL, S., KESSLER, S.W., AGRICOLA, B.A., SELLERS, S., KIRBY, M., DUNBAR, C.E., BRADY, R.O., NIEHUIS, A.W., and DONAHUE, R.E. (1995). Long-term in vivo expression of the human glucocerebrosidase gene in nonhuman primates after CD34+ hematopoietic cell transduction with cell-free retroviral vector preparations. Proc. Natl. Acad. Sci. U.S.A. 92, 4372-4376.
17. YU, M., LEAVITT, M.C., MARUYAMA, M., YAMADA, O., YOUNG, D., HO, A.D., and WONG-STAAL, F. (1995). Intracellular immunization of human fetal cord blood stem/progenitor cells with a ribozyme against human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. U.S.A. 92, 699-703.